Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.

Abstract	INS37217 [P(1)-(uridine 5')-P(4)-(2'-deoxycytidine 5')tetraphosphate, tetrasodium salt] is a deoxycytidine-uridine dinucleotide with agonist activity at the P2Y(2) receptor. In primate lung tissues, the P2Y(2) receptor mRNA was located by in situ hybridization predominantly in epithelial cells and not in smooth muscle or stromal tissue. The pharmacologic profile of INS37217 parallels that of UTP, leading to increased chloride and water secretion, increased cilia beat frequency, and increased mucin release. The combined effect of these actions was confirmed in an animal model of tracheal mucus velocity that showed that a single administration of INS37217 significantly enhanced mucus transport for at least 8 h after dosing. This extended duration of action is consistent with the ability of INS37217 to resist metabolism by airway cells and sputum enzymes. The enhanced metabolic stability and resultant increased duration of improved mucociliary clearance may confer significant advantages to INS37217 over other P2Y(2) agonists in the treatment of diseases such as cystic fibrosis.
Authors	B R Yerxa, J R Sabater, C W Davis, M J Stutts, M Lang-Furr, M Picher, A C Jones, M Cowlen, R Dougherty, J Boyer, W M Abraham, R C Boucher
Journal	The Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 302 Issue 3 Pg. 871-80 (Sep 2002) ISSN: 0022-3565 [Print] United States
PMID	12183642 (Publication Type: Comparative Study, Journal Article)
Chemical References	Chlorides Deoxycytosine Nucleotides Indicators and Reagents Mucins Ophthalmic Solutions P2RY2 protein, human Polyphosphates Purinergic P2 Receptor Agonists Receptors, Purinergic P2 Receptors, Purinergic P2Y2 Uracil Nucleotides purinoceptor P2Y4 diquafosol denufosol tetrasodium Calcium Uridine
Topics	Animals Astrocytoma (metabolism) Brain Neoplasms (metabolism) Calcium (metabolism) Chlorides (metabolism) Cilia (drug effects) Cystic Fibrosis (drug therapy) Deoxycytosine Nucleotides (pharmacology) Epithelial Cells (drug effects) Humans In Situ Hybridization In Vitro Techniques Indicators and Reagents Macaca mulatta Mucins (metabolism) Mucociliary Clearance (drug effects) Ophthalmic Solutions (pharmacology) Polyphosphates Purinergic P2 Receptor Agonists Receptors, Purinergic P2 (biosynthesis, genetics) Receptors, Purinergic P2Y2 Reverse Transcriptase Polymerase Chain Reaction Sheep Tumor Cells, Cultured Uracil Nucleotides Uridine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!